Views & Analysis Imparare a convivere con la LHON Ogni paziente affronta il viaggio della vita a modo proprio, imparando a conoscere la malattia al meglio delle proprie possibilità e attraverso gli strumenti a disposizione.
News Merck rare tumour drug Ezmekly backed for NHS use Merck's drug for tumours associated with rare disease neurofibromatosis type 1, Ezmekly, has been cleared for NHS use in children as young as two.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.